⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 7, 2024Open Access

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Alyssa C. Flint Dana K. Mitchell Steven P. Angus Abbi E. Smith Waylan Bessler Li Jiang Henry Mang Xiaohong Li Qingbo Lu Brooke Rodriguez George E. Sandusky Andi R. Masters Chi Zhang Pengtao Dang Jenna Koenig Gary L. Johnson Weihua Shen Jiangang Liu Amit Aggarwal Gregory P. Donoho Melinda D. Willard Shripad V. Bhagwat D. Wade Clapp Steven D. Rhodes

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Statistics from DESeq2

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Flint et al. (2024) studied this question.

synapsesocial.com/papers/68e7556db6db6435876cd6cb https://doi.org/10.1158/1078-0432.25359769.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma2024
2Table S5 from Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma2024
3Table S5 from Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma2024
4Table S1 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma2024
5Table S1 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma2024